Cardiogenesis combines stem cell delivery tech with heart laser therapy:
This article was originally published in Clinica
Cardiogenesis has completed the first cardiac revascularisation surgery involving the use of its angina-relieving heart laser therapy combined with its investigational stem cell delivery system. During a heart bypass operation, surgeons in China used the firm's Phoenix revascularisation delivery system to administer stem cells precisely to heart tissue surrounding the channels created by the firm's Transmyocardial Revascularisation laser; the channels are believed to promote the growth of new blood vessels. "The Phoenix delivery system is a priority development program for the company, which we expect to implement with both our surgical and percutaneous-laser myocardial revascularisation platforms," said Michael Quinn, the Foothill Ranch, California firm's chairman and CEO.